Clinical trial registry record

Pilot Study on Evaluating the Geroprotective Effect of Metformin

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registry ID
NCT06459310
Last registry update
March 21, 2025
Status
Recruiting
Phase
PHASE2
Sponsor
Xuanwu Hospital, Beijing
Enrollment
130
Countries
China
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 80% confidence

Published automatically with 80% topic confidence after controlled-term evaluation.

  • Metformin · 80%Legacy trial evaluated automatically against controlled title, summary, and longevity-context rules.

Source quality 100% · freshness 65%. These are automated routing signals, not medical or evidence-strength ratings.